NCT06161636 Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease
| NCT ID | NCT06161636 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2020-02-19 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2020-02-19 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The working hypotheses are as follows: #1 The processing of performance signals by automated lognormal segmentation and the extraction of the parameters of interest will make it possible to distinguish groups of patients from healthy elderly subjects. #2 The three instrumental approaches will not have the same degree of reliability as a predictive biomarker of clinical diagnosis established by consensus.
Eligibility Criteria
Inclusion Criteria: * Being diagnosed with Parkinsonism including idiopathic Parkinson's disease or a related syndrome; * Have motor symptoms of Parkinsonism for 6 years or less; * Be a healthy volunteer subject in good general health with no prior neurological history; * Age between 50-75 years old; * If applicable, be able to safely leave home in the morning without having taken antiparkinsonian medication for the past 12 hours. Exclusion Criteria: * Major neurocognitive disorders; * History of other neurological conditions, such as ischemic or hemorrhagic stroke, paralysis of a limb, traumatic brain injury, epilepsy, orofacial dystonia, essential tremor; * History of oromandibular or laryngeal procedures; * Uncorrected deafness; * Any contraindication to pupillary dilation.
Contact & Investigator
Pierre Blanchet
PRINCIPAL INVESTIGATOR
CHUM/Université de Montréal
Frequently Asked Questions
Who can join the NCT06161636 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 75 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06161636 currently recruiting?
Yes, NCT06161636 is actively recruiting participants. Contact the research team at pierre.j.blanchet@umontreal.ca for enrollment information.
Where is the NCT06161636 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06161636 clinical trial?
NCT06161636 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM). The principal investigator is Pierre Blanchet at CHUM/Université de Montréal. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.